Fresenius Kabi To Strengthen And Diversify Product Portfolio By Acquiring Akorn And Merck KGaA's Biosimilars Business

Features Dow Jones Newswires

Dow Jones received a payment from EQS/DGAP to publish this press release.

Continue Reading Below

@DJMTF

(END) Dow Jones Newswires

April 24, 2017 17:10 ET (21:10 GMT)